Stephen L. Hoffman

Active 1964–2024

212
Papers
29,789
Citations
103
h-index
205
i10-index

Citations

Citations per year for Stephen L. Hoffman1966: 1 citations1967: 1 citations1968: 3 citations1969: 3 citations1970: 1 citations1971: 3 citations1972: 2 citations1976: 1 citations1982: 2 citations1983: 3 citations1984: 1 citations1985: 2 citations1986: 8 citations1987: 21 citations1988: 23 citations1989: 17 citations1990: 21 citations1991: 38 citations1992: 42 citations1993: 26 citations1994: 59 citations1995: 59 citations1996: 71 citations1997: 79 citations1998: 133 citations1999: 208 citations2000: 241 citations2001: 252 citations2002: 259 citations2003: 312 citations2004: 321 citations2005: 255 citations2006: 222 citations2007: 231 citations2008: 243 citations2009: 200 citations2010: 230 citations2011: 184 citations2012: 199 citations2013: 218 citations2014: 191 citations2015: 210 citations2016: 152 citations2017: 237 citations2018: 209 citations2019: 777 citations2020: 830 citations2021: 749 citations2022: 615 citations2023: 421 citations2024: 531 citations2025: 233 citations2026: 10 citations1973–1975: no citations, so these years are not shown1977–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,766 citing papers, 28.9% of this breakdownUnited Kingdom: 955 citing papers, 10% of this breakdownAustralia: 494 citing papers, 5.2% of this breakdownGermany: 452 citing papers, 4.7% of this breakdownFrance: 350 citing papers, 3.6% of this breakdownSwitzerland: 324 citing papers, 3.4% of this breakdownNetherlands: 291 citing papers, 3% of this breakdownIndia: 252 citing papers, 2.6% of this breakdownChina: 239 citing papers, 2.5% of this breakdownCanada: 211 citing papers, 2.2% of this breakdownThailand: 188 citing papers, 2% of this breakdownJapan: 180 citing papers, 1.9% of this breakdown
0%28.9%Other 30%

Fields

  • Medicine58.8%
  • Immunology and Microbiology16.6%
  • Biochemistry, Genetics and Molecular Biology13.4%
  • Agricultural and Biological Sciences2.7%
  • Neuroscience2.6%
  • Computer Science1.4%
  • Other4.5%

Topics

  • Malaria Research and Control14.6%
  • Mosquito-borne diseases and control8.4%
  • vaccines and immunoinformatics approaches4.4%
  • Immunotherapy and Immune Responses4.1%
  • Invertebrate Immune Response Mechanisms2.4%
  • T-cell and B-cell Immunology2.2%
  • Other63.9%

Coauthors

All papers

Open in search
  1. Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2021 cited by 237

  2. Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response

    Authors: , , , , , , , , , , , , , , , - Cell Host & Microbe 2020 cited by 182

  3. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martha Sedegah, Awalludin Sutamihardja, Gary A. Fahle, Kirsten E. Lyke, Matthew B. Laurens, Mario Roederer, Kavita Tewari, Judith E. Epstein, B. Kim Lee Sim, Julie E. Ledgerwood, Barney S. Graham, Stephen L. Hoffman, the VRC 312 Study Team, Cassandra DiGiovanni, Pernell Williams, Nicole Luongo, Jillian Mitchell, Maria Burgos Florez, Brenda Larkin, Nina M. Berkowitz, Brandon Wilson, Tanya Clarke, Olga Vasilenko, Galina V. Yamshchikov, Sandra Sitar, LaChonne Stanford, Iris Pittman, Robert T. Bailer, Joseph P. Casazza, Hope DeCederfelt, Judith Starling, Esther C. Williams, Anna F. Lau, Stella Antonara, Jeffery Brocious, Margaret A. Kemp, James Inglese, Patricia Dranchak, Esteban Abot, Sharina Reyes, Harini Ganeshan, María Belmonte, Jun Huang, Arnel Belmonte, Jack Komisar, Yonas Abebe, Yeab Getachew, Asha Patil, Steve Matheny, K. E. Nelson, James Overby, Virak Pich, Yingda Wen, Richard Fan, Enni Fomumbod, Aderonke Awe, Chinnamma Chakiath, Mary D. King, Maria Socorro Orozco, Tooba Murshedkar, Debbie Padilla, Bing Jiang, Lixin Gao, Natasha KC, Rui Xu, Matthew Adams, Christopher V. Plowe, Hayley Loblein, Phyllis Renehan, Meghan Kunchai and 1 more - Science 2013 cited by 784

  4. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Photini Sinnis, Sangeeta N. Bhatia, Stefan H. I. Kappe, B. Kim Lee Sim, Stephen L. Hoffman, Fidel Zavala, Marie Pancera, Robert A. Seder - Nature Medicine 2018 cited by 314

  5. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew B. Laurens, Christopher V. Plowe, Barbara J. Flynn, William R Whalen, John Paul Todd, Jay Noor, Srinivas S. Rao, Kailan Sierra-Davidson, Geoffrey M. Lynn, Judith E. Epstein, Margaret A. Kemp, Gary A. Fahle, Sebastian A. Mikolajczak, Matthew Fishbaugher, Brandon K. Sack, Stefan H. I. Kappe, Silas A. Davidson, Lindsey S. Garver, Niklas K. Björkström, Martha Nason, Barney S. Graham, Mario Roederer, B. Kim Lee Sim, Stephen L. Hoffman, Julie E. Ledgerwood, Robert A. Seder - Nature Medicine 2016 cited by 375

  6. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen L. Hoffman, Peter G. Kremsner - Nature 2017 cited by 412

  7. Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8 + T Cell Immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Edelman, Thomas L. Richie, Robert A. Seder, Stephen L. Hoffman - Science 2011 cited by 546

  8. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric R. James, Michael Walther, Thomas L. Richie, Stephen L. Hoffman, Ogobara K. Doumbo, Patrick E. Duffy - The Lancet Infectious Diseases 2017 cited by 319

  9. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter F. Billingsley, B. Kim Lee Sim, Thomas L. Richie, Irfan Zaidi, Stephen L. Hoffman, Patrick E. Duffy - Nature 2021 cited by 114

  10. Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 103

  11. The optimization of helper T lymphocyte (HTL) function in vaccine development

    Authors: , , , , , , , , , , - Immunologic Research 1998 cited by 146

  12. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen L. Hoffman, Ogobara K. Doumbo, Patrick E. Duffy - The Lancet Infectious Diseases 2021 cited by 79

  13. A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 228

  14. Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires

    Authors: , , , , , , , , , - The Journal of Immunology 1998 cited by 661

  15. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew B. Laurens, Christopher V. Plowe, Thomas L. Richie, Barney S. Graham, Mario Roederer, B. Kim Lee Sim, Julie E. Ledgerwood, Stephen L. Hoffman, Robert A. Seder - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 253

  16. γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations

    Authors: , , , , , , , , , , , , , , , , - The Journal of Immunology 2017 cited by 115

  17. A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - npj Vaccines 2022 cited by 49

  18. Protection of Humans against Malaria by Immunization with Radiation‐AttenuatedPlasmodium falciparumSporozoites

    Authors: , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2002 cited by 687

  19. Protection against Plasmodium falciparum malaria by PfSPZ Vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natasha KC, Minglin Li, Esteban Abot, Arnel Belmonte, Kevin Hauns, María Belmonte, Jun Huang, Carlos Vásquez, Shon Remich, Mary Carrington, Yonas Abebe, Amy Tillman, Bradley Hickey, Jason A. Regules, Eileen Villasante, B. Kim Lee Sim, Stephen L. Hoffman - JCI Insight 2017 cited by 254

  20. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marcel Tanner, Salim Abdulla, Stephen L. Hoffman - American Journal of Tropical Medicine and Hygiene 2018 cited by 164

  21. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2018 cited by 79

  22. PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

    Authors: , , , , , , , , , , , , , - PLoS Pathogens 2021 cited by 59

  23. A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2022 cited by 52

  24. A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 86